|
|
Previous Article | Table of Contents | Next Article 
Band 3 Peptides Block the Adherence of Sickle Cells to Endothelial Cells In Vitro
Bernard J.-M. Thevenin,
Ian Crandall,
Samir K. Ballas,
Irwin W. Sherman, and
Stephen B. Shohet
From the Department of Laboratory Medicine, University of California, San Francisco; the Department of Biology, University of California, Riverside, CA; and the Cardeza Foundation, Thomas Jefferson University, Philadelphia, PA.
Malaria-parasitized erythrocytes have increased endothelial adherence due to exposure of previously buried intramembranous sites of band 3. Because sickle erythrocytes also show increased adhesiveness and because the membrane portion of band 3 is aggregated in both types of cells, we examined the role of band 3 in sickle cell adhesiveness. Synthetic peptides derived from the second and third exofacial, interhelical regions of band 3 completely inhibited the abnormal adherence of sickle cells to an endothelial monolayer in a static assay. This effect was observed independently of plasma factors, required micromolar levels of peptide, was sequence-specific, and was found with both L- and D-isomers. The active peptides also inhibited the increased adherence induced by low-dose calcium loading of normal red blood cells. Finally, a monoclonal antibody against an active peptide specifically immunostained a fraction of sickle cells. These findings implicate a role for band 3 in at least one type of sickle cell adhesiveness via the exposure of normally cryptic membrane sites.
Blood, Vol. 90 No. 10 (November 15), 1997:
pp. 4172-4179
© 1997 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Koshkaryev, S. Yedgar, H. Relevy, E. Fibach, and G. Barshtein
Acridine orange induces translocation of phosphatidylserine to red blood cell surface
Am J Physiol Cell Physiol,
September 1, 2003;
285(3):
C720 - C722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Gallagher, S. H. Chang, M. P. Rettig, J. E. Neely, C. A. Hillery, B. D. Smith, and P. S. Low
Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis
Blood,
June 1, 2003;
101(11):
4625 - 4627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Matsui, A. Varki, and S. H. Embury
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
Blood,
November 15, 2002;
100(10):
3790 - 3796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Y. Setty, S. Kulkarni, and M. J. Stuart
Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion
Blood,
March 1, 2002;
99(5):
1564 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Y. Setty, S. Kulkarni, C. D. Dampier, and M. J. Stuart
Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion
Blood,
May 1, 2001;
97(9):
2568 - 2573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Manodori, G. A. Barabino, B. H. Lubin, and F. A. Kuypers
Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
Blood,
February 15, 2000;
95(4):
1293 - 1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Harlan
Introduction: anti-adhesion therapy in sickle cell disease
Blood,
January 15, 2000;
95(2):
365 - 367.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jarolim, H.L. Rubin, D. Zakova, J. Storry, and M.E. Reid
Characterization of Seven Low Incidence Blood Group Antigens Carried by Erythrocyte Band 3 Protein
Blood,
December 15, 1998;
92(12):
4836 - 4843.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|